Literature DB >> 22835603

Non-Hodgkin lymphoma.

Kate R Shankland1, James O Armitage, Barry W Hancock.   

Abstract

Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological appearances and clinical features at presentation, which can make diagnosis difficult. Lymphomas are not rare, and most physicians, irrespective of their specialty, will probably have come across a patient with lymphoma. Timely diagnosis is important because effective, and often curative, therapies are available for many subtypes. In this Seminar we discuss advances in the understanding of the biology of these malignancies and new, available treatments.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835603     DOI: 10.1016/S0140-6736(12)60605-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  186 in total

1.  Atypical measles syndrome in adults: still around.

Authors:  Cléa Melenotte; Nadim Cassir; Laurent Tessonnier; Philippe Brouqui
Journal:  BMJ Case Rep       Date:  2015-09-23

2.  Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma.

Authors:  Nathan H Fowler; Loretta J Nastoupil; Frederick B Hagemeister; Sattva S Neelapu; Luis E Fayad; Denise LeBlanc; Felipe Samaniego; Chan Yoon Cheah
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

3.  Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab.

Authors:  Alice Cho; Bridget Bradley; Robert Kauffman; Lalita Priyamvada; Yevgeniy Kovalenkov; Ron Feldman; Jens Wrammert
Journal:  JCI Insight       Date:  2017-06-15

4.  Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma.

Authors:  Dong Won Baek; Hee Jeong Cho; Ju-Hyung Kim; Sang Kyun Sohn; Ga-Young Song; Seo-Yeon Ahn; Sung-Hoon Jung; Jae Sook Ahn; Je-Jung Lee; Hyeoung-Joon Kim; Shin-Young Jeong; Chae Moon Hong; Jung-Joon Min; Joon-Ho Moon; Deok-Hwan Yang
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

5.  Histopathological Features and Ann Arbor Stage in Periocular Lymphoma.

Authors:  Marco Zschoche; Annette Zimpfer; Björn O Scheef; Anselm M Jünemann; Rudolf F Guthoff; Christian Junghanss; Guido Hildebrandt; Steffen Emmert; Andreas Erbersdobler; Günther Kundt; Vinodh Kakkassery
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

6.  A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma.

Authors:  Tao Li; Lijuan Niu; Lili Wu; Xia Gao; Man Li; Wenxuan Liu; Lei Yang; Dianwu Liu
Journal:  Tumour Biol       Date:  2014-12-13

7.  Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.

Authors:  Yanchun Wang; Zhongguang Luo; Yongfu Pan; Weige Wang; Xiaoyan Zhou; Lak Shin Jeong; Yiwei Chu; Jie Liu; Lijun Jia
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

8.  Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.

Authors:  Andrew M Harrison; Nassir M Thalji; Alexandra J Greenberg; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

9.  Unilateral lower extremity swelling as a rare presentation of non-Hodgkin's lymphoma.

Authors:  Islam Y Elgendy; Margaret C Lo
Journal:  BMJ Case Rep       Date:  2014-01-15

10.  Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.

Authors:  Beata Holkova; Maciej Kmieciak; Prithviraj Bose; Victor Y Yazbeck; Paul M Barr; Mary Beth Tombes; Ellen Shrader; Caryn Weir-Wiggins; April D Rollins; Erin M Cebula; Emily Pierce; Megan Herr; Heidi Sankala; Kevin T Hogan; Wen Wan; Changyong Feng; Derick R Peterson; Richard I Fisher; Steven Grant; Jonathan W Friedberg
Journal:  Leuk Lymphoma       Date:  2015-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.